drugset / Trial / NCT00860288
Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a 2-3 period parallel group study with an adaptive element in Type 2 diabetes patients receiving vildagliptin as add-on therapy to metformin
Timeline
- Start
- 2009-02
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sitagliptin | Small molecule | — | — |
| Subject | Vildagliptin | Other / unclassified | — | — |
| Background | Metformin | Small molecule | — | — |